You can buy or sell VKTX and other stocks, options, ETFs, and crypto commission-free!
Viking Therapeutics, Inc. Common Stock, also called Viking Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for patients suffering from metabolic and endocrine disorders. Read More The company's clinical program VK5211, treats patients recovering from non-elective hip fracture surgery. It also specializes in development of VK2809 and VK0214. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
San Diego, California
52 Week High
52 Week Low
Expected Nov 6, After Hours